{"id":38535,"date":"2025-08-04T15:00:50","date_gmt":"2025-08-04T07:00:50","guid":{"rendered":"https:\/\/flcube.com\/?p=38535"},"modified":"2025-08-04T15:00:50","modified_gmt":"2025-08-04T07:00:50","slug":"tennor-therapeutics-submits-listing-application-to-hong-kong-stock-exchange-main-board","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=38535","title":{"rendered":"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board"},"content":{"rendered":"\n<p>China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main Board of the Hong Kong Stock Exchange on July 30, 2025. CITIC Securities and ABC International are serving as joint sponsors for the listing.<\/p>\n\n\n\n<p><strong>Company Overview<\/strong><br>Founded in 2012, TenNor Therapeutics is a biotechnology company nearing commercialization. It specializes in the development of differentiated innovative drugs for bacterial infections and metabolism-related diseases. The company is equipped with a proprietary multi-target conjugated molecule technology platform and has established a robust pipeline of seven innovative assets.<\/p>\n\n\n\n<p><strong>Core Products<\/strong><\/p>\n\n\n\n<p><strong>TNP-2198 (Rifabutin Nitazoxanide)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The world&#8217;s first new molecular entity candidate for treating H. pylori infection, featuring a multi-target synergistic mechanism.<\/li>\n\n\n\n<li>Phase III China registration clinical trial completed; New Drug Application (NDA) expected to be submitted in China before the end of August 2025.<\/li>\n<\/ul>\n\n\n\n<p><strong>TNP-2092 Injection (Rifabutin Quinolone)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A potential first-in-class triple-target antibacterial drug for implant-related bacterial infections.<\/li>\n<\/ul>\n\n\n\n<p><strong>TNP-2092 Oral Formulation<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Designed for the treatment of metabolism-related diseases involving the gut microbiome.<\/li>\n<\/ul>\n\n\n\n<p><strong>Commercialization and Clinical Success<\/strong><br>In 2023, TenNor Therapeutics signed a commercialization agreement for TNP-2198 with Grand Life Science. According to registration clinical trial data, TNP-2198 triple therapy (RTT) demonstrated superior efficacy, safety, and compliance compared to bismuth quadruple therapy (BQT), particularly in patients with multi-drug resistance.<\/p>\n\n\n\n<p><strong>Financial Overview<\/strong><br>As of March 31, 2025, TenNor Therapeutics reported cash and cash equivalents of RMB 146 million and net current liabilities of RMB 932 million. The company has completed seven rounds of financing, raising a cumulative RMB 733 million. Following its Series E round in March 2025, the company achieved a post-money valuation of RMB 2.013 billion.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/sehk25073001780_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk25073001780_c.\"><\/object><a id=\"wp-block-file--media-3213cfe9-9718-4a75-bd7f-ba33b6ebc632\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/sehk25073001780_c.pdf\">sehk25073001780_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/sehk25073001780_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-3213cfe9-9718-4a75-bd7f-ba33b6ebc632\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main&#8230;<\/p>\n","protected":false},"author":1,"featured_media":38539,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[72,2192],"class_list":["post-38535","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ipo","tag-tennor-therapeutics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main Board of the Hong Kong Stock Exchange on July 30, 2025. CITIC Securities and ABC International are serving as joint sponsors for the listing.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=38535\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board\" \/>\n<meta property=\"og:description\" content=\"China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main Board of the Hong Kong Stock Exchange on July 30, 2025. CITIC Securities and ABC International are serving as joint sponsors for the listing.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=38535\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T07:00:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0499.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board\",\"datePublished\":\"2025-08-04T07:00:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535\"},\"wordCount\":274,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0499.webp\",\"keywords\":[\"IPO\",\"TenNor Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38535#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=38535\",\"name\":\"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0499.webp\",\"datePublished\":\"2025-08-04T07:00:50+00:00\",\"description\":\"China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main Board of the Hong Kong Stock Exchange on July 30, 2025. CITIC Securities and ABC International are serving as joint sponsors for the listing.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38535\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0499.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/0499.webp\",\"width\":1080,\"height\":608,\"caption\":\"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38535#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board - Insight, China&#039;s Pharmaceutical Industry","description":"China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main Board of the Hong Kong Stock Exchange on July 30, 2025. CITIC Securities and ABC International are serving as joint sponsors for the listing.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=38535","og_locale":"en_US","og_type":"article","og_title":"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board","og_description":"China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main Board of the Hong Kong Stock Exchange on July 30, 2025. CITIC Securities and ABC International are serving as joint sponsors for the listing.","og_url":"https:\/\/flcube.com\/?p=38535","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-08-04T07:00:50+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0499.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=38535#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=38535"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board","datePublished":"2025-08-04T07:00:50+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=38535"},"wordCount":274,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=38535#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0499.webp","keywords":["IPO","TenNor Therapeutics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=38535#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=38535","url":"https:\/\/flcube.com\/?p=38535","name":"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=38535#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=38535#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0499.webp","datePublished":"2025-08-04T07:00:50+00:00","description":"China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main Board of the Hong Kong Stock Exchange on July 30, 2025. CITIC Securities and ABC International are serving as joint sponsors for the listing.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=38535#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=38535"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=38535#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0499.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0499.webp","width":1080,"height":608,"caption":"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=38535#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/0499.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38535"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38535\/revisions"}],"predecessor-version":[{"id":38540,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38535\/revisions\/38540"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/38539"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}